Our mission: redefine diseases using patient data to accelerate drug discovery for patients in need
PROBLEM:
|
OUR SOLUTION:
|
HOW WE DO IT:
Unravel begins with patients, using their RNA to define each disease using molecular data. Our proprietary model of human health predicts drugs to restore a disease back to health, and our unbiased screening platform selects drugs that work in a whole organism, letting us ask clinically-relevant questions from the start. We then use these drugs to find new, hidden drug targets, validate them in the clinic, and develop new therapies.
The result: we decode patients' diseases to enable effective therapeutics, quickly and with lower development risk.
Unravel begins with patients, using their RNA to define each disease using molecular data. Our proprietary model of human health predicts drugs to restore a disease back to health, and our unbiased screening platform selects drugs that work in a whole organism, letting us ask clinically-relevant questions from the start. We then use these drugs to find new, hidden drug targets, validate them in the clinic, and develop new therapies.
The result: we decode patients' diseases to enable effective therapeutics, quickly and with lower development risk.
We can't do this alone.
|
We are committed to getting patients effective drugs the fastest way possible. We partner with companies, foundations, and researchers to amplify their strengths and datasets through cost-effective decision-making in the areas of target discovery, mechanism identification, drug optimization, and patient stratification for small molecules and biologics.
|